Literature DB >> 3088223

Three-phase white blood cell scan: diagnostic validity in abdominal inflammatory diseases.

W Becker, W Fischbach, C Reiners, W Börner.   

Abstract

Indium-111-oxine saline-labeled "mixed" leukocyte (n = 16) and "pure" granulocyte (n = 66) scans were prospectively performed as "three-phase" white blood cell (WBC) scans (imaging: 30 min, 4 hr, and 24 hr after reinjection of the cells) in 82 patients suspected of having abdominal or retroperitoneal abscesses or inflammatory lesions. Inflammation was verified histologically, endoscopically, radiologically or by autopsy in 51 and excluded in 31 patients. Sensitivity, specificity, and diagnostic accuracy of the 30-min scan (90%, 56%, 72%) were statistically significantly lower than the 4-hr scan (96%, 97%, 98%). Of the 24-hr scan sensitivity, specificity, and diagnostic accuracy were only 84%, 98%, and 89% because many patients with chronic inflammatory bowel diseases had excreted a portion of intestinal 111In activity by 24 hr. The overall sensitivity, specificity, and accuracy of the "three-phase" WBC scan were 98%, 97%, and 98%, respectively. Only one female patient showed a false-positive scan with granulocyte uptake in an ulcerating adenocarcinoma of the colon. The 4-hr scan or the three-phase study are recommended because of their high sensitivity, specificity, and excellent diagnostic accuracy (98%). The 30-min scan is less specific (56%); the 24-hr scan less sensitive (84%). The three-phase study additionally allows the differentiation between inflammatory bowel diseases and abscesses because it allows observation of granulocyte kinetics for 24 hr.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088223

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  The 111In-granulocyte scan in prosthetic vascular graft infections: imaging technique and results.

Authors:  W Becker; W Düsel; P Berger; W Spiegel
Journal:  Eur J Nucl Med       Date:  1987

2.  Intestinal accumulation of 111In-granulocytes in patients studied because of occult infection.

Authors:  M T Syrjälä; K Liewendahl; V Valtonen; J Gripenberg
Journal:  Eur J Nucl Med       Date:  1987

3.  Intense accumulation of indium-111 leukocytes in peritonitis carcinomatosa.

Authors:  N Ishikawa; T Takeda; K Nakajima; M Satoh; A A Qureshi; M Akisada; T Todoroki; K Orii; K Saitoh
Journal:  Ann Nucl Med       Date:  1989-03       Impact factor: 2.668

4.  Image quality and radiopharmaceutical parameters of indium-111 granulocytes in scintigraphy of inflammatory bowel disease.

Authors:  J W Arndt; G E Crama-Bohbouth; H W Verspaget; D Blok; A S Pena; R T Tham; I T Weterman; C B Lamers; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1989

5.  Use of immunoscintigraphy in the diagnosis of fever of unknown origin.

Authors:  W Becker; U Dölkemeyer; M Gramatzki; M U Schneider; J Scheele; F Wolf
Journal:  Eur J Nucl Med       Date:  1993-11

6.  Labelled leucocyte scintigraphy in inflammatory bowel disease: clinical applications.

Authors:  M H Giaffer
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

7.  Computed tomography and granulocyte scintigraphy in active inflammatory bowel disease. Comparison with endoscopy and operative findings.

Authors:  J J Kolkman; T H Falke; J C Roos; D H Van Dijk; I M Bannink; W Den Hollander; M A Cuesta; A S Peña; S G Meuwissen
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

8.  Evaluation of white cell scintigraphy using indium-111 and technetium-99m labelled leucocytes.

Authors:  S J Boyd; R Nour; R J Quinn; E McKay; S P Butler
Journal:  Eur J Nucl Med       Date:  1993-03

Review 9.  The contribution of nuclear medicine to the patient with infection.

Authors:  W Becker
Journal:  Eur J Nucl Med       Date:  1995-10

10.  Kinetic data of in-vivo labeled granulocytes in humans with a murine Tc-99m-labelled monoclonal antibody.

Authors:  W Becker; U Borst; W Fischbach; B Pasurka; R Schäfer; W Börner
Journal:  Eur J Nucl Med       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.